BackBiora Therapeutics Overview

Biora Therapeutics Other Liabilities

Biora Therapeutics's other liabilities is $-14M.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$-13.83M

Peer average

Loading

Biora Therapeutics Other Liabilities History

Loading

Biora Therapeutics vs. peers: Other Liabilities Comparison

Loading

Biora Therapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biora Therapeutics (BIOR) FAQ

Biora Therapeutics (BIOR) currently reports a other liabilities of $-14M as of September 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore Biora Therapeutics's other liabilities history and peer comparisons.

Biora Therapeutics's other liabilities changed from $0 to $-14M (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biora Therapeutics reported $-14M in other liabilities as of September 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $-14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biora Therapeutics, and consider following BIOR for alerts when major investors trade the stock.

Biora Therapeutics is classified in the Healthcare sector. On other liabilities, it currently shows $-14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOR with unrelated industries.